Preliminary analyses have found dysregulated expression of imprinted genes involved in tumor suppression (e.g., Pleiomorphic Adenoma Gene-Like 1 (PLAGL1) and Hydatidiform Mole Associated and Imprinted (HYMAI)) in cervical cancer specimen compared to normal cervical tissue [18], and Maternally Expressed Gene 3 (MEG3) hypermethylation has been implicated as a potential biomarker in cervical cancer [19]. The gene discussed is HYMAI; the disease is cervical cancer.